Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)

NCT01387269 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Cachexia
Non-Small Cell Lung Cancer

Interventions

DRUG: Anamorelin HCl
DRUG: Placebo

Sponsor

Helsinn Therapeutics (U.S.), Inc